Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Motivational interviewing is a collaborative, conversational counseling method developed by William Miller and Stephen Rollnick that is focused on helping individuals articulate and resolve ambivalence about change[1][2][3][4][5][6][7][8]. It emphasizes respect for client autonomy, empathy, and acceptance, engaging people as equal partners to empower them in setting and achieving their own goals for change. Initially developed for addiction medicine, MI is now widely used across fields such as mental health, chronic disease management, and health promotion. Its core techniques include open-ended questions, reflective listening, affirmations, and eliciting "change talk," all within the broader "spirit" of partnership, compassion, and respect for self-determination[1][2][3][4][5][6][7][8]. MI is not a biochemical or therapeutic target, and does not involve molecular interactions or pharmacological mechanisms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Motivational interviewing (MI).